Dossier
American Society of Health-System Pharmacists
Coverage of American Society of Health-System Pharmacists in the Nexus archive.
- STAT+: Pharmalittle: We’re reading about rising drug shortages, GSK coughing up a trial loss, and more
The U.S. experienced 227 active medication shortages in Q2 2026, with 48% being sole-source products and 10% involving life-saving contrast agents. GSK abandoned development of camlipixant, a chronic cough drug acquired for $2 billion, after Phase 3 trials showed limited efficacy.
- STAT+: Pharmalittle: We’re reading about Medicare and Alzheimer’s drugs, estrogen patch shortages, and more
People on Medicare are not getting recently approved Alzheimer's medications as much as anticipated, and uptake for the drugs has been muted. Meanwhile, there is a shortage of estrogen patches, with doctors and patients reporting difficulties in getting certain doses. The U.S. Food and Drug Administration has not yet included any estrogen patches on its list of drug shortages.